September 30, 2018 · Pincode* 500038 Contact no.* 040-23738398 Fax no. 040 -23738398 ... Telephone...

8
October 08, 2018 The Corporate Relationship Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai- 400001 GlaxoSmithKline Consumer Healthcare Ltd. 24-25 Floor, One Horizon Center Sector 43, DLF Phase 5, Golf Course Road Gurugram (Haryana), India - 122002 T +91 124 4336500 F +91 124 4336600 E [email protected] www.gsk.com The Listing Compliance Department National Stock Exchange of India Limited Exchange Plaza, C - 1, Block - G Sandra Kurla Complex, Sandra Mumbai - 400 051 Sub: Reconciliation of Share Capital Audit Report for the second quarter ended on September 30, 2018 Dear Sir I Madam, Pursuant to Regulation 55A of SEBI (Depositories & Participants) Regulations, 1996, we are enclosing herewith the Reconciliation of Share Capital Audit Report for the Second Quarter ended September 30, 2018. Please take the same on your record. Thanking You, For GlaxoSmithKline Consumer Healthcare Limited _/1~ Shanu Saksena \12. Company Secretary CIN : L24231PB1958PLC002257 Registered Office Patiala Road Nabha (Punjab), India 147201

Transcript of September 30, 2018 · Pincode* 500038 Contact no.* 040-23738398 Fax no. 040 -23738398 ... Telephone...

October 08, 2018

The Corporate Relationship Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai- 400001

GlaxoSmithKline Consumer Healthcare Ltd. 24-25 Floor, One Horizon Center Sector 43, DLF Phase 5, Golf Course Road Gurugram (Haryana), India - 122002

T +91 124 4336500 F +91 124 4336600 E [email protected] www.gsk.com

The Listing Compliance Department National Stock Exchange of India Limited Exchange Plaza, C - 1, Block - G Sandra Kurla Complex, Sandra Mumbai - 400 051

Sub: Reconciliation of Share Capital Audit Report for the second quarter ended on September 30, 2018

Dear Sir I Madam,

Pursuant to Regulation 55A of SEBI (Depositories & Participants) Regulations, 1996, we are enclosing herewith the Reconciliation of Share Capital Audit Report for the Second Quarter ended September 30, 2018.

Please take the same on your record.

Thanking You,

For GlaxoSmithKline Consumer Healthcare Limited

_/1~ Shanu Saksena

\12. Company Secretary

CIN : L24231PB1958PLC002257 Registered Office Patiala Road Nabha (Punjab), India 147201

10/8/2018 GSK55 ..... html

RECONCILIATION OF SHARE CAPITAL AUDIT

Scrip code* 500676

NSESymbol GSKCONS

MSEI Symbol NOT LISTED

!SIN INE264A01014

Name of the company* GLAXOSMITHKLINE CONSUMER HEALTHCARE LIMITED

Registered office address

Registered office address* PATIALA ROAD, NABHA-147201

Registered office state* PUNJAB

Registered office city* NABHA

Registered office district* NABHA

Registered office pin code* 147201

Registered office contact ISD Code* STD Code* Number*

number* +91 01765 306400

Registered office fax 01765 220642

. Registered office countty* INDIA

Registered office website www.gsk.com

Registered office email [email protected]

Correspondence address

Same as above No

C01Tespondence address 24th FLOOR, ONE HORIZON CENTER, SECTOR 43, DLF PHASE 5, GOLF COURSE ROAD, GURUGRAM

Correspondence state HARYANA

CoITespondence city GURUGRAM

Correspondence district GURUGRAM

C01Tespondence pin code 122002

CotTespondence contact !SD Code STD Code Number

number +9 1 124, 4336500

Correspondence fax 124 4336600

Correspondence country INDIA

Correspondence email [email protected]

Repo1ting quarter* 30-09-2018

Face value* 10

Stock Exchange Details : Name of stock Exchange Listed % Of total issued Capital capital

BSELtd 42055538 100 Name of other stock exchanges where the company's securities are listed National Stock Exchange .oflndia

42055538 100 Ltd(NSE)

Remarks

file:///Z:/Personal%20Folders/Rishubh/2018-19/Stock%20exchange%20Submissions/Regulation%2055/bse/GSK55 ... .. html 1/5

10/8/2018 GSK55 ... .. htrnl

Capital Details :

Number of shares % Of total issued capital

Issued capital* 42055538

Listed capital (BSE) (As per company records)* 42055538 100

Held in dematerialised form in CDSL * 845114 2.01

Held in dematerialised form in NSDL * 40543906 96.41

Physical* 666518 1.58

Total no.of shares* 42055538 100

Reasons for difference if any, Between issued capital and listed capital* 0

Reasons for difference if any, Between issued capital and total number of shares* 0

Reasons for difference if any, Between listed capital and total number of shares* 0

fi le:///Z:/Personal%20Folders/Rishubh/2018-19/Stock%20exchange%20Subrnissions/Regulation%2055/bse/GSK55 ..... html 2/5

10/8/2018 GSK55 .. ... html

Certifying the details of changes in share capital during the quarter under consideration as per Table below:

Whether changes during the quarter*

Register of members is updated* Yes

Ifi1ot, Updated upto which date

Reference of previous quarter with regards to excess dematerialised shares,lfany. NIL

Has the company resolved the matter (excess dematerialised shares mentioned above) in the cunent quaiter ?* NA

If not, Reason why ?

fi le:///Z:/Personal%20Folders/Rishubh/2018-19/Stock%20exchange%20Submissions/Regulation%2055/bse/GSK55 ..... html 3/5

10/8/2018 GSK55 ..... html

Mentioned the total no.of requests, If any, confirmed after 21 days and the total no.of requests pending beyond 21 days with the reasons for delay

Total no.of demat requests No.of requests* No.of shares* Reasons for delay

Confumed after 21 days* 0 0

Pending for more than 21 days* 0 0

Remarks

Compliance Officer Details

Name of the compliance officer* Shanu Saksena

Designation* Company secreta1y

Membership Nos 9733

Telephone no.* 0124-4336500

Fax no. 0124-4336600

E-mail id* [email protected]

file:///Z:/Personal%20F olders/Rishubh/2018-19/Stock%20exchange%20Submissions/Regulation%2055/bse/GSK55 ... .. html 4/5

10/8/2018 GSK55 ..... html

Certifying Auditor Details

CA/CS* Company secretaiy

Name of ce1tifying auditor* S. ANAND S.S.RAO

Date of issue of report* 08-10-2018

Address* 511, KANCHANJUNGA BLOCK, ADITYA ECLAVE, AMEERPET, HYDERABAD - 500038

City* HYDERABAD

Pincode* 500038

Contact no.* 040-23738398

Fax no. 040 -23738398

Email

Membership no. 5716

Firms registration number of audit firm

Name of the fom* S. ANAND S.S.RAO

COP number 5687

Registrar and Share Transfer Agent Details

Appointment of common agency for share registry work* Yes

NameofRTA KARVY COMPUTERSHARE PRIVATE LIMITED

SEBI registration no. INR00000022 l

Address KARVY SELENIUM TOWER B, PLOT 31-32, GACHIBOWLI, FINANCIAL DISTRICT

State HYDERABAD

City NANAKRAMGUDA

Pincode 500032

Contact no. 9140-67161500

Fax number ofRTA 9140-67161500

E-mail id [email protected] ·

Website Address https://www.karvy.com

Any other detail that the auditor may like to provide. (e.g. BIFR company, delisting from SE)

fi le:///Z:/Personal%20Folders/Rishubh/2018-19/Stock%20exchange%20Submissions/Regulation%2055/bse/GSK55 ... .. html 5/5

Us S ANAND SS RAO M.Com., LLB., F.C.S

COMPANY SECRETARY IN PRACTICE

Flat No.511, Kanchanjunga Adltya Enclave, Ameerpet, Hyderabad - 500038. Mobile 092461 536 77 Tele 040 23738398 Fax 040 23738398 E-mail [email protected] Website www.anandssrao.com

RECONCILIATION OF SHARE CAPITAL AUDIT REPORT FOR THE QUARTER ENDED 30 09 2018.

1. Report for quarter ended

2. ISIN 3. Face Value 4. Name of the Company

5. Registered Office Address 6. Correspondence Address

7. Telephone and Fax Nos.

8 Email Address

9. Name of the Stock Exchange where the company's Securities are listed:

30 09 2018 INE264A01014

Rs. I 0/- each

GlaxoSmithKline Consumer Healthcare Limited Patiala Road, Nabha - 147 201 24th Floor, One Horizon Center, DLF Phase 5, Golf Course Road, Gurgaon 122002, India Tel +0124 - 4336266 Fax+ 0124 - 4336600

[email protected] Bombay Stock Exchange Limited National Stock Exchange of India Limited

Number of Shares % of Total Issued Capital

10. Issued Capital 42055538 100 11. Listed Capital (Exchange Wise) All 42055538 100

(as per company records)

12. Held in dematerialised form in CDSL 845114 2.01 13. Held in dematerialised form in.NSDL 40543906 96.41 14. Physical 666518 1.58 15. Total No. of Shares (12+13+14) 42055538 100.00

16. Reasons for differences if any, between I NA (10&11),(10&15),(11&15) '-· -----------------'

17. Certifying the details of changes in share capital during the quarter under consideration as per Table below: Particulars No. of Applied/ Listed on Stock Whether Whether In-principle

Shares Not Exchange intimated intimated approval Pending Applied for (Specify name) to CDSL toNSDL from Stock listing Exchange(s)

(Specify Names) NIL

18. Register of Members is updated (Yes /No) -YES-If not, updated upto which date -N.A-

19. Reference of previous quarter with regard to excess dematerialized shares, if any: -NIL-

20. Has the Company resolved the matter mentioned in Point No.19 above, in the current quarter? If not reason why? -NA-21. Mention the total no. of requests, if any, confirmed after 21 days and the total no. ofrequests pending b dld "hh f<dl NIL evon 2 avs wit t e reasons or e av. - -

No. ofrequests Confirmed after 21 days -NIL-Pending for more than 21 days -NIL-

22. Name, Telephone & Fax No. of Compliance Officer of the company

23. Name, Address, Telephone & Fax No., Regn no. of the Auditor

24. Appointment of common agency for share registry work (if yes, name and address)

No. of shares Reasons for delay -NIL- -NIL--NIL- -NIL-

Ms. Shanu Saksena, Company Secretary-Appointed wef 05-08-2016 Ph : 0124 4336500 Fax: 0124 4336600 [email protected] Auditor of this Report: S.ANAND S.S.RAO

Company Secretary in Practice, C.P. No.5687,M.No.FCS 5716 511, Kanchanjunga Block, Aditya Enclave, Ameerpet, Hyderabad -500 038 Phone: (M) 092461-53677 Phone No:040-237 38 39 8 Fax No. 040-237 38 39 8 Karvy Computershare Private Limited, Karvy Selenium Tower B, Plot 31-32, Gachibowli, Financial District, Nanakramguda, Hyderabad - 500 032 Phone No. (91 40) 6716 1500

25. Any other detail that the auditor may like to provide, (e.g. BIFR Company, delisting from Stock Exchange, company changed its name etc.:- NIL

Place: Hyderabad,

Date: 08-10-2018. ~ S. Anand SS Rao,

Company Secretary in Practice, CP.No.5687 I FCS No.5716.